We are live on ! Find out more
TCP

Tourbillon Capital Partners Portfolio holdings

AUM $6.26M
1-Year Est. Return 42.29%
This Fund
S&P 500
This Quarter Est. Return
+9.72%
1 Year Est. Return
-42.29%
3 Year Est. Return
-18.38%
5 Year Est. Return
+32.21%
10 Year Est. Return
–
AUM
$4.6B
AUM Growth
+$719M
Cap. Flow
+$372M
Cap. Flow %
8.09%
Top 10 Hldgs %
41.73%
Holding
134
New
61
Increased
20
Reduced
15
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$122M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$102M
3
TCOM icon
Trip.com Group
TCOM
+$94.8M
4
VYX icon
NCR Voyix
VYX
+$81.4M
5
PARA
Paramount Global Class B
PARA
+$72.5M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$108M
2
BKD icon
Brookdale Senior Living
BKD
+$75.5M
3
CMG icon
Chipotle Mexican Grill
CMG
+$68.3M
4
CRI icon
Carter's
CRI
+$65.2M
5
BRCM
BROADCOM CORP CL-A
BRCM
+$61.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.04%
2 Technology 8.76%
3 Consumer Staples 8.59%
4 Healthcare 8.44%
5 Communication Services 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VDTH
76
DELISTED
Videocon d2h Limited
VDTH
$14M 0.3%
+1,108,500
New +$12.8M
CIT
77
CALL
DELISTED
CIT Group Inc.
CIT
$13.9M 0.3%
+300,000
New +$14M
TXN icon
78
PUT
Texas Instruments
TXN
$245B
$12.9M 0.28%
+250,000
New +$13.8M
ADXS
79
DELISTED
Advaxis Inc
ADXS
$11.2M 0.24%
+36,667
New +$11.6M
AXTA icon
80
Axalta
AXTA
$7.79B
$10.8M 0.23%
+325,000
New +$10.7M
RXDX
81
DELISTED
Ignyta, Inc.
RXDX
$9.58M 0.21%
+635,000
New +$7.68M
SSYS icon
82
CALL
Stratasys
SSYS
$695M
$8.73M 0.19%
+250,000
New +$10.5M
PLXP
83
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$8.27M 0.18%
+81,250
New +$8.41M
GNCA
84
DELISTED
Genocea Biosciences, Inc.
GNCA
$8.18M 0.18%
74,425
+24,375
+49% +$2.26M
ARAV
85
DELISTED
Aravive, Inc. Common Stock
ARAV
$7.53M 0.16%
82,500
+49,167
+148% +$4.98M
AM
86
CALL
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
$7.16M 0.16%
+250,000
New +$6.72M
IOVA icon
87
Iovance Biotherapeutics
IOVA
$1.93B
$6.96M 0.15%
+759,400
New +$8.48M
ELDN icon
88
Eledon Pharmaceuticals
ELDN
$264M
$6.88M 0.15%
3,191
– –
AVG
89
PUT
DELISTED
AVG Technologies N.V.
AVG
$6.8M 0.15%
+250,000
New +$6.09M
SNR
90
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$6.68M 0.15%
+500,000
New +$7.93M
PGR icon
91
Progressive
PGR
$122B
$5.57M 0.12%
+200,000
New +$5.45M
WW
92
CALL
DELISTED
WW International
WW
$4.85M 0.11%
+1,000,000
New +$6.65M
SGYP
93
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$3.88M 0.08%
+467,800
New +$2.27M
ANAC
94
CALL
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$3.87M 0.08%
+50,000
New +$3.28M
ANAC
95
PUT
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$3.87M 0.08%
+50,000
New +$3.28M
ADVM
96
CALL
DELISTED
Adverum Biotechnologies
ADVM
$1.38M 0.03%
8,510
– –
ENR icon
97
Energizer
ENR
$1.48B
$510K 0.01%
+15,000
New +$508K
ABUS icon
98
Arbutus Biopharma
ABUS
$873M
– –
-275,000
Closed -$4.8M
ACAD icon
99
Acadia Pharmaceuticals
ACAD
$4.41B
– –
-400,000
Closed -$13M
ADVM
100
DELISTED
Adverum Biotechnologies
ADVM
– –
-53,000
Closed -$17.9M
2 3
4
5 6

Similar funds

BC
Blueport Capital Fort Worth, Texas $5.8M AUM 4.95% 1-Year Est. Return
LBG
Lloyds Banking Group London, United Kingdom $7.15M AUM 0.75% 1-Year Est. Return
TGA
Trilogy Global Advisors Winter Park, Florida $712K AUM 8.54% 1-Year Est. Return
ACM
Archer Capital Management New York $16.2M AUM 17.01% 1-Year Est. Return
MGFS
Miller Green Financial Services Spring, Texas $17.6M AUM
LA
Lexington Advisors New York $18.7M AUM 48.36% 1-Year Est. Return
CT
CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return
NMM
NGP MR Management Dallas, Texas $23.4M AUM 15.8% 1-Year Est. Return

Tourbillon Capital Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Tourbillon Capital Partners held 134 positions worth $4.6B, up 19% from $3.88B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Tourbillon Capital Partners deployed $372M of net new capital in Q2 2015, opening 61 new positions and adding to 20 existing holdings. Its largest new stake was Apple: 3,800,000 shares worth $119M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Broadcom, an estimated $108M trimmed.

  • Tourbillon Capital Partners's largest Q2 2015 buy was Apple: 3,800,000 shares worth $119M.
  • Tourbillon Capital Partners added most to Trip.com Group in Q2 2015, an estimated $94.8M increase.
  • Tourbillon Capital Partners's biggest Q2 2015 reduction was Broadcom, cutting an estimated $108M.
  • Tourbillon Capital Partners fully exited Brookdale Senior Living in Q2 2015, selling an estimated $75.5M.
  • Tourbillon Capital Partners's ten largest holdings make up 42% of its $4.6B portfolio in Q2 2015.
  • Tourbillon Capital Partners opened 61 new positions and closed 36 in Q2 2015.
  • Tourbillon Capital Partners's portfolio value rose 19% quarter-over-quarter to $4.6B.

Based on Tourbillon Capital Partners's 13F filing for Q2 2015, filed 14 Aug 2015.